TY  - GEN
AU  - Chen,Tai-Tsang
TI  - Predicting analysis times in randomized clinical trials with cancer immunotherapy
SN  - 1471-2288
PY  - 2016///1017
KW  - Algorithms
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Clinical Trials, Phase III as Topic
KW  - methods
KW  - Dacarbazine
KW  - Humans
KW  - Immunotherapy
KW  - Ipilimumab
KW  - Kaplan-Meier Estimate
KW  - Melanoma
KW  - drug therapy
KW  - Models, Theoretical
KW  - Neoplasms
KW  - immunology
KW  - Outcome Assessment, Health Care
KW  - Prognosis
KW  - Randomized Controlled Trials as Topic
KW  - Reproducibility of Results
KW  - Research Design
KW  - Retrospective Studies
KW  - Time Factors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s12874-016-0117-3
ER  -